Andrographolide (ANDR) has been shown to be effective in the treatment of ovarian and breast cancers, inducing activation of caspase-8,FLIP and XIAP, promoting tumor pyroptosis and apoptosis, and inhibiting invasive metastasis [105]. The gene discussed is CASP8; the disease is neoplasm.